334 related articles for article (PubMed ID: 24064012)
1. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
[TBL] [Abstract][Full Text] [Related]
2. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
3. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
[TBL] [Abstract][Full Text] [Related]
4. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
Ahmadi M; Yousefi M; Abbaspour-Aghdam S; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Khabbazi A; Rostamzadeh D; Alipour S; Shabani M; Nouri M; Babaloo Z
J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
[TBL] [Abstract][Full Text] [Related]
5. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.
Chi W; Zhu X; Yang P; Liu X; Lin X; Zhou H; Huang X; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3058-64. PubMed ID: 18579762
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
[TBL] [Abstract][Full Text] [Related]
7. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.
Shimizu J; Izumi T; Arimitsu N; Fujiwara N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Takai K; Suzuki N
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S35-9. PubMed ID: 22935165
[TBL] [Abstract][Full Text] [Related]
8. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
[TBL] [Abstract][Full Text] [Related]
9. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
Li B; Xie C; Lin X; Su SB
Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
Shen H; Xia LP; Lu J
Scand J Rheumatol; 2013; 42(1):48-51. PubMed ID: 23101722
[TBL] [Abstract][Full Text] [Related]
12. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
Wang C; Tian Y; Ye Z; Kijlstra A; Zhou Y; Yang P
Arthritis Res Ther; 2014 May; 16(3):R117. PubMed ID: 24887071
[TBL] [Abstract][Full Text] [Related]
13. IL-18 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behçet's disease.
Hamzaoui A; Ghraïri H; Ammar J; Zekri S; Guemira F; Hamzaoui K
Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S8-14. PubMed ID: 14727452
[TBL] [Abstract][Full Text] [Related]
14. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
[TBL] [Abstract][Full Text] [Related]
15. Association of Reduced Heme Oxygenase-1 with Decreased MicroRNA-196a2 Expression in Peripheral Blood Mononuclear Cells of Patients with Intestinal Behcet's Disease.
Zou J; Ji DN; Shen Y; Guan JL; Zheng SB
Ann Clin Lab Sci; 2016 Dec; 46(6):675-679. PubMed ID: 27993883
[TBL] [Abstract][Full Text] [Related]
16. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behçet Disease Uveitis.
Albayrak O; Oray M; Can F; Uludag Kirimli G; Gul A; Tugal-Tutkun I; Onal S
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):52-63. PubMed ID: 30601931
[TBL] [Abstract][Full Text] [Related]
17. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
Liu X; Wang C; Ye Z; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6012-7. PubMed ID: 23908180
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Behçet's disease.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S56-S63. PubMed ID: 27156371
[TBL] [Abstract][Full Text] [Related]
20. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease.
Liu X; Yang P; Wang C; Li F; Kijlstra A
Rheumatology (Oxford); 2011 Feb; 50(2):293-8. PubMed ID: 21059671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
